Latest filing published 09 Feb 2017 for Bellicum Pharmaceuticals, INC, €350k.
Filing timeline
BuySaleInsider track record
Kevin M. Slawin: trading record in brief
All filings by Kevin M. Slawin on record concern Bellicum Pharmaceuticals, Inc. In total, 41 filings cover trades dated from 23 December 2014 to 7 February 2017.
No open-market purchase appears, only 28 sales worth €4.1M. In 2017 alone, the filings show no purchases and 1 sale.
On 9 February 2017 came the latest disclosure, an open-market sale for €350k in Bellicum Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kevin M. Slawin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,000 shares@ US$12.5410.0% of flowCommon StockSEC:0001358403-17-000032:0
- 30,000 shares@ US$15.4512.5% of flowCommon StockSEC:0001358403-16-000309:0
- 100 shares@ US$20.040.1% of flowCommon StockSEC:0001358403-16-000273:0
- 11,258 shares@ US$20.125.7% of flowCommon StockSEC:0001358403-16-000273:2
- 11,958 shares@ US$20.116.1% of flowCommon StockSEC:0001358403-16-000273:3
- 942 shares@ US$20.000.5% of flowCommon StockSEC:0001358403-16-000263:0
- 636 shares@ US$20.000.3% of flowCommon StockSEC:0001358403-16-000263:1
- 1,400 shares@ US$20.020.7% of flowCommon StockSEC:0001358403-16-000263:2
- 1,206 shares@ US$20.010.6% of flowCommon StockSEC:0001358403-16-000263:3
- 300 shares@ US$20.000.2% of flowCommon StockSEC:0001358403-16-000263:4
- 100 shares@ US$20.000.1% of flowCommon StockSEC:0001358403-16-000263:5
- 34,127 shares@ US$19.2716.7% of flowCommon StockSEC:0001358403-16-000255:0
- 1,873 shares@ US$20.011.0% of flowCommon StockSEC:0001358403-16-000255:1
- 29,000 shares@ US$19.2714.2% of flowCommon StockSEC:0001358403-16-000255:2
- 2,000 shares@ US$20.011.0% of flowCommon StockSEC:0001358403-16-000255:3
- 15,000 shares@ US$15.005.8% of flowCommon StockSEC:0001358403-16-000239:0
- 22,281 shares@ US$13.727.8% of flowCommon StockSEC:0001358403-16-000231:0
- 2,719 shares@ US$13.991.0% of flowCommon StockSEC:0001358403-16-000233:0
- 25,000 shares@ US$11.437.2% of flowCommon StockSEC:0001358403-16-000166:0
- 29,800 shares@ US$11.428.6% of flowCommon StockSEC:0001358403-16-000166:1
- 200 shares@ US$11.890.1% of flowCommon StockSEC:0001358403-16-000166:2
- 14,000 shares@ US$20.65Common StockSEC:0001358403-15-000095:1
- 4,000 shares@ US$20.65Common StockSEC:0001358403-15-000095:2
- 6,000 shares@ US$20.65Common StockSEC:0001358403-15-000095:0
- 1,500 shares@ US$20.00Common StockSEC:0001358403-15-000057:0
25 of 40 declarations
